
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
In this episode, we spoke with an expert about the potential impacts of new guidelines on adolescents, as well as the risks associated with new anti-obesity drugs.
In this episode, we spoke with expert Jennifer Salvon, RPh, about the potential impacts of new guidelines on adolescents, as well as the risks associated with new anti-obesity drugs.





